EUVIMED · CrossrefZeitschrift
Cancer Letters
ISSN 0304-3835 · Elsevier BV
Neueste Artikel
Saturation mutagenesis library screening identifies on-target secondary resistance mutations in KRASG12D-selective inhibitors
Reprogramming muscle proteostasis in cancer cachexia: Transcriptional mechanisms and therapeutic opportunities
Atovaquone impedes muscle wasting in pancreatic cancer by AMPK modulation
Comment on the Chinese guidelines for the diagnosis and treatment of pediatric craniopharyngioma (2025)
Event-free survival in patients with early triple-negative breast cancer receiving platinum-free, de-escalated anti-PD-1 neoadjuvant therapy: an updated analysis of the NeoTENNIS trial
SAGE1-mediated H3K27ac enrichment promotes chromatin opening and Fanconi Anemia repair to induce carboplatin resistance in triple-negative breast cancer
Metabolic stress rewires DHODH from oncogenesis to SLC7A11-driven disulfidptosis and radiosensitization in esophageal squamous cell carcinoma
Macrophage-derived WNT regulates tumor immune microenvironment to reduce colitis-associated colon cancer
MDK+ cancer-associated fibroblasts promote immunotherapy resistance through mitochondrial reprogramming in breast cancer
CHK1/2 as a potential therapeutic target in Neurofibromatosis type 2 schwannomas
CRISPR-based interrogation of alternative lengthening of telomeres: mapping dependencies, stress-buffering pathways, and therapeutic vulnerabilities
Repurposing antimalarial drug atovaquone in combination with radiation and PD-L1 checkpoint blockade to enhance antitumour response in head and neck squamous cell carcinoma (HNSCC)
Acute MCL1 loss via homoharringtonine-mediated translational inhibition enables potent apoptotic synergy with BCLXL blockade
Next-generation CAR-macrophage therapies: Design principles and advances in cancer treatment
Verbascoside inhibits ovarian cancer proliferation via IRAK4-CXCL5 axis-mediated suppression of neutrophil infiltration and neutrophil extracellular trap formation
Targeting CDC7 overcomes gemcitabine resistance in cholangiocarcinoma by inducing cellular senescence
Four clinical lenses for interpreting the Chinese guideline for pediatric craniopharyngioma
Oncogenic circPRRC2B regulates redox homeostasis via stabilizing TALDO1 protein of the pentose phosphate pathway in esophageal squamous cell carcinoma
UBL3 modification reduces nuclear POLE levels to potentiate antitumor immunity in aero-upper digestive squamous cell carcinomas
Tumor-like alterations in brain tissue adjacent to glioblastoma: an integrated analysis based on continuous en bloc resection strategy
Extracellular vesicle–mediated strategies for cancer tissue normalisation
LRH-1 is a novel regulator of neutrophil-driven immune responses within the tumor microenvironment
Spatial plasticity and multidirectional crosstalk of cancer-associated adipocytes in therapy-remodeled niches
AMPK signaling in cancer: Molecular insights and therapeutic opportunities
Early WEE1 inhibition prevents senescence-like epigenetic reprogramming of pioneer TMZ-resistant cells and synergizes with temozolomide in MYC-high glioblastoma
Erianin targets glutathione reductase to trigger immunogenic cell death and sensitize pancreatic cancer to PD-1 blockade
CDK9 degradation suppresses gastroesophageal cancer growth and overcomes radiation resistance through chromatin remodeling and YAP1/TEAD downregulation
MUC16 drives macrophage-mediated immunosuppression in pancreatic cancer
Lactate-induced PPP1R1B upregulation drives resistance to neoadjuvant immunotherapy in NSCLC via IRF3 dephosphorylation
Immune checkpoint inhibitor therapy in COPD-concomitant lung cancer: A review of efficacy outcomes and mechanistic insights
Jahrgänge
2027 · 72026 · 5392025 · 5812024 · 6372023 · 3392022 · 4222021 · 5192020 · 4642019 · 4592018 · 5662017 · 5192016 · 5352015 · 5602014 · 4562013 · 5482012 · 3652011 · 3592010 · 3812009 · 4582008 · 4692007 · 4922006 · 5242005 · 5002004 · 4992003 · 4732002 · 4362001 · 4372000 · 4331999 · 4081998 · 4501997 · 4571996 · 5241995 · 4691994 · 4001993 · 2661992 · 2651991 · 2251990 · 2721989 · 2191988 · 275
EUVIMED